Mitesh

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners (our members), the Department has today (01/06/2023) announced the following final list of price concessions for May 2023: Drug Pack size Price concession Amoxicillin 125mg/5ml oral suspension 100 £2.98 Amoxicillin 250mg/5ml oral [...]

The post May 2023 Price Concessions Final Update appeared first on Community Pharmacy England.

Community Pharmacy England on behalf of our members made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 10 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 June 2023. This takes the total [...]

The post 10 products added to the Discount Not Deducted (DND) list from June 2023 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has provided clarification from HMRC that VAT is not applicable on products supplied in accordance with serious shortage protocols (SSPs). From 1 June 2023, the allowance for VAT currently paid alongside product reimbursement will stop being paid when reimbursing for products supplied in accordance with SSPs. Until [...]

The post SSP VAT changes from 1 June 2023 appeared first on Community Pharmacy England.

From June 2023, the Department of Health and Social Care (DHSC) has updated its definition of Hormone Replacement Therapy to include two more products to the list of HRT medicines covered by the new HRT prepayment certificate (HRT PPC). The new additions include: Tibolone 2.5mg tablets (Livial®) Prasterone 6.5mg pessaries (Intrarosa®) The June 2023 Drug Tariff (Part XVI) [...]

The post Two new products added to the HRT PPC medicines list from June 2023 appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 10 May 2023) has been published and includes articles on: Direct-acting oral anticoagulants (DOACs): paediatric formulations; reminder of dose adjustments in patients with renal impairment Glucose solutions: recommendations to minimise the risks associated with the accidental use of glucose solutions [...]

The post MHRA Drug Safety Update May 2023 appeared first on PSNC Website.